D.E. Shaw & Co’s Dimension Therapeutics, Inc DMTX Stock Holding History

D.E. Shaw & Co’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-72,978	Closed	-$438K	–	3927
2017 Q3	$438K	Buy	+72,978	New	+$189K	﹤0.01%	2978
2016 Q4	–	Sell	-13,297	Closed	-$106K	–	3786
2016 Q3	$106K	Sell	13,297 -7,380	-36%	-$53.4K	﹤0.01%	3281
2016 Q2	$124K	Buy	20,677 +4,827	+30%	+$36.8K	﹤0.01%	3235
2016 Q1	$124K	Sell	15,850 -3,958	-20%	-$31.2K	﹤0.01%	3265
2015 Q4	$223K	Buy	+19,808	New	+$251K	﹤0.01%	3511

D.E. Shaw & Co's DMTX Position: Q4 2017 in Review

D.E. Shaw & Co sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 72,978 shares — an estimated $438K sold.

D.E. Shaw & Co first reported a position in DMTX in Q4 2015 and held it in 5 quarters. The position peaked at $438K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

D.E. Shaw & Co reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
D.E. Shaw & Co sold 72,978 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $438K.
D.E. Shaw & Co first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 5 quarters.
D.E. Shaw & Co's Dimension Therapeutics, Inc position peaked at $438K in Q3 2017.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.